Sunday, November 1, 2026

EUR/CHF Bullish Momentum With A 1% Jump In The Last 21 Sessions

EUR/CHF Bullish Momentum With A 1% Jump In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.86% for the last 21 sessions. At 08:06 EST on Friday, 8 March, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 6.179% up from its 52-week low and 4.082% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was 0.15%, 0.11%, and 0.23%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.22% (last week), 0.20% (last month), and 0.23% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be oversold (<=20).

News about

  • Eur/usd edges up after unexpected rise in German trade surplus. According to FXStreet on Wednesday, 6 March, "The EUR/USD pair is seeing alift on Wednesday, trading up by almost two tenths of a percent against the US Dollar (USD) after the release of Eurozone Retail Sales data showed shoppers continued spending fairly liberallyin January."
  • Eur/usd rises on soft ADP jobs data, fed chairman powell’s remarks. According to FXStreet on Wednesday, 6 March, "Thus, the EUR/USD edges up 0.42% and trades at 1.0881 after hitting a two-week high of 1.0887."
  • Eur/usd forex signal: extremely bullish ahead of ECB decision - 06 March 2024. According to DailyForex on Wednesday, 6 March, "The EUR/USD pair rose after the encouraging European services and composite PMI numbers. ", "The EUR/USD continued its slow recovery as focus shifted to the upcoming ADP jobs data and the interest rate decision by the European Central Bank (ECB). "
  • Eur/usd forex signal: weakly bullish above $1.0881 - 07 March 2024. According to DailyForex on Thursday, 7 March, "My previous EUR/USD signal on 5thMarchproduced a profitable short trade from the bearish reversal at $1.0872.", "In my previous analysis ofthe EUR/USD currency pairon Tuesday, I wrote that price action had become marginally more bullish, so we were poised eventually for a bullish breakout beyond $1.0872, but I thought this was very unlikely to happen today."
  • According to FXStreet on Wednesday, 6 March, "In the meantime, further gains lifted Gold to a new record high, and EUR/USD broke above 1.0900."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com